affno abstract
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis2002· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
347
citations